Top

Neurological Sciences

Published in:

27-06-2022 | Myasthenia Gravis | COVID-19

The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis

Author: Giuliana Galassi

Published in: Neurological Sciences | Issue 10/2022

Excerpt

To the Editor …

Rodrigues CL, de Freitas HC, Lima PRO, de Oliveira Junior PH, Fernandes JMA, D’Almeida JAC, Nóbrega PR (2022) Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review. Neurol Sci 18:1–6. https://doi.org/10.1007/s10072-021-05823-wCrossRef

Jaretzki A 3rd, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory board of the myasthenia gravis foundation of America. Neurology 12(55):16–23. https://doi.org/10.1212/wnl.55.1.16CrossRef

Delly F, Syed MJ, Lisak RP, Zutshi D (2020) Myasthenic crisis in COVID-19. J Neurol Sci 15(414):116888. https://doi.org/10.1016/j.jns.2020.116888CrossRef

Zhao W, Zhong Z, Xie X, Yu Q, Liu J (2020) Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. AJR Am J Roentgenol 214(5):1072–1077. https://doi.org/10.2214/AJR.20.22976CrossRefPubMed

Solé G, Mathis S, Friedman D, Salort-Campana E, Tard C, Bouhour F, Magot A, Annane D, Clair B, Le Masson G, Soulages A, Duval F, Carla L, Violleau MH, Saulnier T, Segovia-Kueny S, Kern L, Antoine JC, Beaudonnet G, Audic F, Kremer L, Chanson JB, Nadaj-Pakleza A, Stojkovic T, Cintas P, Spinazzi M, Foubert-Samier A, Attarian S (2021) Impact of coronavirus disease 2019 in a French cohort of myasthenia gravis. Neurology 96(16):e2109–e2120. https://doi.org/10.1212/WNL.0000000000011669CrossRefPubMed

Murthy JMK, Gutta AK, Yerasu MR, Boorgu SK, Osman S, Jaiswal SK, Pidaparthi L, Gudavalli BP (2021) COVID-19 in patients with myasthenia gravis: mechanisms of respiratory failure. Neurol India 69(6):1772–1776. https://doi.org/10.4103/0028-3886.333460CrossRefPubMed

Jakubíková M, Týblová M, Tesař A, Horáková M, Vlažná D, Ryšánková I, Nováková I, Dolečková K, Dušek P, Piťha J, Voháňka S, Bednařík J (2021) Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival. Eur J Neurol 28:3418–3425. https://doi.org/10.1111/ene.14951CrossRefPubMedPubMedCentral

RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ (2021) Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 384:693–704. https://doi.org/10.1056/NEJMoa2021436CrossRef

Title: The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis
Author: Giuliana Galassi
Publication date: 27-06-2022
Publisher: Springer International Publishing
Keywords: Myasthenia Gravis
SARS-CoV-2
COVID-19
Published in: Neurological Sciences / Issue 10/2022
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-022-06206-5

At a glance: The STEP trials

Springer Medicine

The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2022

Investigation of postural control and spatiotemporal parameters of gait during dual tasks in ataxic individuals

MS diagnosis in a male patient with m.11778G > A Leber’s hereditary optic neuropathy

Serum TG/HDL-C level at the acute phase of ischemic stroke is associated with post-stroke cognitive impairment

Low serum uric acid levels are associated with incidence and severity in trigeminal neuralgia

Paradoxical embolic stroke: giant coronary aneurysms, myxoma, and PFO

Trigeminal neuropathy as presenting symptom of craniofacial venous metameric syndrome